{"id":"molybdenum-mo-99","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":["NCT03002454"],"aliases":[],"patents":[],"pricing":[],"allNames":"99mo","offLabel":[],"synonyms":["Molybdenum Mo-99","Molybdenum-99","99Mo","Molybdenum isotope of mass 99"],"timeline":[],"brandName":"99Mo","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine a special kind of camera that uses a tiny amount of radioactive material to take pictures of the inside of your body. 99Mo is the starting material that gets converted into this radioactive material, which is then used to create detailed images of your internal organs and tissues.","oneSentence":"99Mo is converted into Tc-99m through a nuclear reaction, which is then used to create diagnostic imaging agents.","technicalDetail":"99Mo undergoes beta decay to form Tc-99m, which is then used as a radiopharmaceutical in various diagnostic imaging procedures, such as bone scans and cardiac stress tests."},"_wikipedia":{"url":"https://en.wikipedia.org/wiki/Isotopes_of_molybdenum","title":"Isotopes of molybdenum","extract":"Molybdenum (42Mo) has seven isotopes in nature, with atomic masses of 92, 94-98, and 100. All are stable except 100Mo, which undergoes double beta decay with a half-life of 7.07×1018 years to 100Ru. 92Mo and 98Mo are also energetically able to decay in this manner, to zirconium and ruthenium respectively; the others are theoretically stable. There are also a total of 32 synthetic isotopes known, and at least 13 metastable nuclear isomers, ranging in atomic mass from 81 to 119."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/4286","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Molybdenum Mo-99","fields":["publications"],"source":"PubMed/NCBI"},{"id":3,"url":"https://en.wikipedia.org/wiki/Isotopes_of_molybdenum","fields":["history","overview"],"source":"Wikipedia"}],"_enrichedAt":"2026-03-30T08:19:14.049683","biosimilars":[],"competitors":[],"dataSources":[{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"},{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"molybdenum mo-99","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03002454","phase":"Phase 3","title":"A Cross-over Comparison of the Diagnostic Accuracy of Technetium (99mTc) Medronate Injection Prepared With 99mTc Derived From Neutron-activation Produced 99Mo Versus the Current Reference Standard of ","status":"TERMINATED","sponsor":"University of Manitoba","isPivotal":true,"enrollment":4,"indication":"Cancer of Bone","completionDate":"2017-01"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"NUI":"N0000146513","UNII":"6634O61GOI","VUID":"4018178","CHEBI":"CHEBI:135936","VANDF":"4018178","RXNORM":"90574","UMLSCUI":"C0303458","PUBCHEM_CID":"104976","MESH_SUPPLEMENTAL_RECORD_UI":"C000615515"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":25,"therapeuticAreas":["Bone"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"99Mo (Molybdenum Mo-99) is a radioactive isotope used in the production of technetium-99m (Tc-99m), a radiopharmaceutical used in medical imaging. It is not a drug itself but a precursor to Tc-99m, which is used in various diagnostic procedures. The exact target and indications for 99Mo are unknown, but its commercial status is that of a patented product. Key safety considerations include proper handling and storage due to its radioactive nature. Further information on its use and safety is limited.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}